Granules gets USFDA's nod for Amphetamine capsules

Amphetamine is bioequivalent to the reference listed drug product (RLD), Adderall XR extended-release capsules of Takeda Pharmaceuticals. This product will be manufactured at Granules manufacturing facility in Chantilly, Virginia, and is expected to be launched shortly, according to a company statement shared with stock exchanges.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/t8Qg40a
via IFTTT

0 comments:

Post a Comment